The winners of the 16th Annual Scrip Awards were announced on 2 December. Our client, John Dawson, CEO at Oxford Biomedica, won Executive of the Year – Companies with market cap <$10bn. Congratulations to him and the Oxford Biomedica team. This has been an incredible year for the industry and we congratulate all the winners below.
Scrip’s Lifetime Achievement Award
Dame Sally Davies
Pharma Company of the Year
AstraZeneca
Best New Drug Award
MSD’s Ervebo (Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live)
WuXi AppTec’s Biotech Company of the Year
Ionis Pharmaceuticals
Community Partnership of the Year
sponsored by Medidata, a Dassault Systemes Company
Takeda’s The Global Challenge: A 100-Day Challenge Towards Healthier Lifestyles For Patients With Bleeding Disorders
Clinical Advance of the Year
sponsored by Parexel
Regeneron’s Phase III PALM trial of REGN-EB3 for Ebola
Executive of the Year – Companies with market cap >$10bn
Kenneth Frazier, chief executive officer of Merck & Co
Executive of the Year – Companies with market cap <$10bn
John Dawson, chief executive officer of Oxford Biomedica
Licensing Deal of the Year
Roche and Dicerna for the siRNA RG6346 for chronic hepatitis B
China Biopharma Leadership Award
AstraZeneca China
Highly Commended: BeiGene
Business Development Team of the Year
Roche and Spark Therapeutics’ Acquisition Liaison Team
Best Contract Research Organization – Full-Service Providers
sponsored by Bioclinica
Parexel
Best Contract Research Organization – Specialist Providers
Illingworth Research Group
Best Partnership Alliance
Amgen, AstraZeneca, GSK and Janssen for the UK Biobank Whole Genome Sequencing Project
Financing Deal of the Year
BioNTech’s $225m series B financing round and $150m IPO on NASDAQ
Innovation Award
BenevolentAI’s artificial intelligence for the discovery of more effective medicines
